Home

Differences

This shows you the differences between two versions of the page.

Link to this comparison view

Both sides previous revisionPrevious revision
home:symptoms:gastrointestinal [03.13.2019] – [Bleeding from bowel] sallieqhome:symptoms:gastrointestinal [09.14.2022] (current) – external edit 127.0.0.1
Line 62: Line 62:
 ==== Further researxh ==== ==== Further researxh ====
  
-Findings suggest that neither olmesartan nor other ARBs were associated with diarrhea among patients undergoing endoscopy. The spruelike enteropathy recently associated with olmesartan is likely a rare adverse effect and milder presentations are unlikely.  (({{pubmed>long:25023670}}))+Findings suggest that neither olmesartan nor other ARBs were associated with diarrhea among patients undergoing endoscopy. The spruelike enteropathy recently associated with olmesartan is likely a rare adverse effect and milder presentations are unlikely.  (({{pmid>long:25023670}}))
  
-In a methotrexate-induced model of intestinal mucositis, olmesartan reduced inflammation and induced enteropathy characterized by severe diarrhea, weight loss, and reduced sucrose activity.   (({{pubmed>long:25947920}}))+In a methotrexate-induced model of intestinal mucositis, olmesartan reduced inflammation and induced enteropathy characterized by severe diarrhea, weight loss, and reduced sucrose activity.   (({{pmid>long:25947920}}))
  
  
  
  
 +<nodisp>
 ===== Notes and comments ===== ===== Notes and comments =====
  
-===== References =====+===== References =====</nodisp> 
home/symptoms/gastrointestinal.txt · Last modified: 09.14.2022 by 127.0.0.1
© 2015, Autoimmunity Research Foundation. All Rights Reserved.